pipette
ESEspañol

PNEUMOCOCCAL CONJUGATE VACCINE SCHEDULES SHAPE SEROTYPE-SPECIFIC MEMORY B-CELL RESPONSES

H. Brown, T. V. Phan, Z. Q. Toh, B. Temple, C. Nguyen, K. Vientrung, H. V. A. Nguyen, N. V. P. Hong, V. T. T. Dai, K. Bright, H. P. Tran, R. A. Higgins, N. Mazarakis, S. Luu, L. Quah, D. G. Pellicci, T. V. Nguyen, J. Anderson, K. Mulholland, P. Licciardi

PreprintReal-world use

In the authors' words

Reduced-dose pneumococcal conjugate vaccine (PCV) schedules (1+1; one primary and one booster) are now endorsed by the World Health Organisation under specific circumstances. Serotype-specific memory B cells (BMEM) are a marker of long-term protection but data from infant reduced-dose trials remain limited. As part of a randomised controlled trial in Vietnamese infants, we characterised serotype-specific BMEM responses in randomised subsets (N=50 per vaccine group per timepoint) following 0+1 (at 12 months of age) or 1+1 (2 and 12 months of age) schedules of PCV10 or PCV13, using a multimer spectral flow cytometry approach. Blood samples were collected at 12 months of age (baseline) and at day 7 and day 28 post-vaccination. A one or two dose schedule of either PCV induced robust serotype-specific BMEM responses at day 7 and day 28 for most serotypes. PCV13 generated earlier and higher BMEM responses than PCV10, while 1+1 schedules for either PCV produced higher BMEM responses than the 0+1 schedules at day 7. By day 28, these differences between the 0+1 and 1+1 schedules were no longer apparent. Notably, BMEM responses for serotypes 6B and 23F were detectable even in infants who did not achieve protective levels of serotype-specific IgG greater or equal to 0.35 ug/mL. PCV13 generated higher plasmablast and plasma cell responses by day 7, and higher cTfh responses by day 28, compared to PCV10. These findings show that 1+1 schedules of PCV10 or PCV13 induce robust BMEM responses, with important implications for the evaluation of PCVs and understanding long-term protection.

Main resultThe abstract does not state a limitation.

Appeared: Wednesday, November 11. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.09.26367657